The Latest Breaking News from Prostate Cancer UK

Decision over routine PSA testing is due at end of this month, though some feel the supporting data is unclear

Three-year study will test biopsy analysis tool shown in trials to identify men likely to benefit from certain drugs

It comes as concerns were raised that a new drug approved for NHS use will not be given to eligible patients.

McGeechan shared his diagnosis in May and underwent treatment, which included a six-week course of radiotherapy

BRCA gene mutations are linked to a higher chance of developing prostate cancer at a younger age and in a more aggressive form

The UK National Screening Committee is reviewing the evidence for an NHS prostate cancer screening programme.

With the backing of Rishi Sunak, Prostate Cancer UK published a report to the national screening committee back in 2022 in support of a targeted program for men at ‘high risk’. So, who are they – and will the government listen? Rebecca Thomas reports

Concerns have also been raised about the proportion of men who were only diagnosed after their disease had spread

Prostate Cancer UK also raised concerns about the proportion of men who were only diagnosed after their disease had spread.